Makale
Tam Makale
Uluslararası
2022
Açık erişimli
Does new onset and pre-existing atrial fibrillation predict mortality in COVID-19 patients?
EGYPTIAN HEART JOURNAL
Cilt 74 · Sayı 1 · 01.07.2022
Özet
Background: Coronavirus Disease-2019 (COVID-19), caused by Severe Acute Respiratory Syndrome-Coronavirus-2, still remains prevalent and severe. We aimed to evaluate the effects of pre-existing atrial fibrillation and new-onset atrial fibrillation (NOAF) on the clinical severity and mortality of COVID-19.
Anahtar kelimeler
COVID-19
Mortality
atrial fibrillation
Sürdürülebilir Kalkınma Amaçları
-
SKA 3: Sağlıklı Bireyler
Atıf için künye
Aydemir, S., Aksakal, E., Aydinyilmaz, F., Gülcü, O., Sarac, I., Aydin, S. Ş., Dogan, R., Lazoglu, M., & Kalkan, K. (2022). Does new onset and pre-existing atrial fibrillation predict mortality in COVID-19 patients? EGYPTIAN HEART JOURNAL, 74(1). https://doi.org/10.1186/s43044-022-00291-9
BibTeX
@article{aydemir2022-228964,
author = {Aydemir, Selim and Aksakal, Emrah and Aydinyilmaz, Faruk and Gülcü, Oktay and Sarac, Ibrahim and Aydin, Sidar Şiyar and Dogan, Remziye and Lazoglu, Merve and Kalkan, Kamuran},
title = {Does new onset and pre-existing atrial fibrillation predict mortality in COVID-19 patients?},
journal = {EGYPTIAN HEART JOURNAL},
year = {2022},
volume = {74},
number = {1},
issn = {1110-2608},
doi = {10.1186/s43044-022-00291-9},
url = {https://akademik.atauni.edu.tr/yayinlar/228964-does-new-onset-and-pre-existing-atrial-fibrillation-predict-mortality-in-covid}
}